Appointment of Non-Executive Director
Bioventix PLC announced the appointment of Chris Yates as an independent Non-Executive Director, effective March 1, 2026, bringing over 20 years of public company experience, including a decade leading Abingdon Health plc where he served as CEO and later President of Abingdon Health USA and Group Chief Commercial Officer. Yates also holds a Non-Executive Director role and chairs the Audit Committee at Genedrive plc and previously served as CFO for Immunodiagnostic Systems Holdings PLC and Cozart plc. He is a Chartered Accountant with an economics degree from the University of Cambridge and currently holds no shares in Bioventix.
Select text to share a quote on X · sign in to keep highlights & notes in your BVXP notes
Bioventix PLC (AIM: BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, is delighted to announce the appointment of Chris Yates as independent Non-Executive Director, with effect from 1st March 2026.
Chris brings extensive board‑level and sector expertise, underpinned by over 20 years' experience operating within publicly listed company environments. Over the past decade, Chris has led the development and growth of Abingdon Health plc. Chris co-founded the business in 2008, initially serving as Non-Executive Director and then in 2015 becoming Chief Executive Officer until 2025 when he was appointed President of Abingdon Health USA and Group Chief Commercial Officer. Chris also serves as a Non-Executive Director and Chairman of the Audit Committee of AIM-listed Genedrive plc. Earlier in his career, Chris was CFO of AIM-listed companies Immunodiagnostic Systems Holdings PLC and Cozart plc.
Chris is a Chartered Accountant and has a degree in economics from the University of Cambridge.
Chris Henry Francis Yates
The following information regarding the appointment of Chris Yates, aged 51, is disclosed under Schedule 2(g) of the AIM Rules for Companies:
| Current directorships and/or partnerships | Past directorships and/or partnerships (within the last five years) |
| Abingdon Analytical Limited | Abingdon Health plc |
| Compliance Solutions (Life Sciences) Limited | Serascience Limited |
IVDeology Holdings Limited
IVDeology Limited
IVDeology UKRP Limited
Molecular Vision Limited
Genedrive plc
Foresite Diagnostics Limited
Find Out from Home Inc.
Abingdon Health USA Inc.
Chris Yates does not hold any shares in Bioventix.
There are no further disclosures to be made under Rule 17 and Schedule 2(g) of the AIM Rules for Companies.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.